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Implications of myocardial reperfusion on survival in women versus 
men with acute myocardial infarction undergoing primary coronary 
intervention
Rahil Hamdadou, Mohamed Chettibi, Redouane Nedjar, Mohamed Tahar 
Bouafia
CHU Frantz Fanon, Cardiologie, Blida, Algérie
Background: The in hospital mortality rate after myocardial infarction is 
higher among women than men. PCI is recommended treatment for ST -seg-
ment elevation myocardial infarction (STEMI) in patients of both genders. It 
is used in women without a clear demonstration of their efficiency in this 
population. It is only extrapolations of studies enrolling a large majority of 
males (more than 85%).It is very important to improve our therapeutic straté-
gies in women, to perform dedicated studies.
Aim: Of our study was to compare clinical and angiographic features in 
men and women and to determine wether gender influenced in – hospital 
prognosis of primary percutaneous coronary intervention.
Methods: We conducted a retrospective study including 282 patients 
admitted in the University hospital of Blida (Alegria). Between April 2009 
and January 2011. All these patients had an ST segment elevation myocardial 
infarction and underwent primary PCI within 12 hours after symptom onset.
Results: Our population counted 239men and 43women. Females were 
significantly older (p<0.05).They had a higher prevalence of diabetes 32.6% 
(P<0.05), hypertension 55.8% (P=0.01), dyslipemia16.3% (P<0.05). They were 
more likely to consult late (Mean time from symptom onset was 299.7±93.9min 
in women vs 296±97.9mn in men (p<0.001). In our study, angiographic success 
was achieved in 76.7% of the cases in women and in 92.1% of the cases in men 
(p=0.005).The in hospital mortality rate was 7% in women and 5% in men 
(p=NS).
Conclusion: There is no gender descrepancy in – hospital mortality in 
patients who undergo emergency PCI for treatment of STEMI. These data 
suggest that gender should not affect the decision to offer PCI but further 
gender specific studies are warranted.
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Relationship of hyperglycemia to the no-reflow phenomenon in ST-
elevation myocardial infarction patients treated by primary percuta-
neous coronary intervention
Ouafa Hamza, Omar Ait Mokhtar, Abdelmalek Azzouz, Nabil Bendaoud, 
Mourad Saidane, Arezki Sik, Samia Latrèche, Khereddine Merad, Salim 
Benkhedda
CHU Mustapha, Cardiologie A2, Alger, Algérie
Background: It has been shown that elevated blood glucose levels on 
admission are associated with worse outcome in ST elevation myocardial 
infarction.
Impaired microvascular function and no-reflow phenomenon seem to be 
one of the underlying mechanisms of hyperglycemia deleterious effects
Aim: To establish the relationship between hyperglycemia on admission 
and the no-reflow phenomenon
Methods: Patients presenting with acute STEMI who underwent primary 
percutaneous coronary intervention (PCI) were enrolled. ST segment resolu-
tion was evaluated at 90 minutes in the worst lead. No-reflow was defined as 
a resolution of ST segment less than 50% in the worst lead at 90 minutes
Results: 102 consecutive patients were enrolled (87 men and 15 women) 
with a mean age of 56.95 ±12.89 years. The no-reflow phenomenon was 
observed in 28 (27.45 %) patients, their glucose level on hospital admission 
was significantly higher than in patients whithout no-reflow phenomenon 
(12.48 ± 7.48 vs. 8.55 ± 2.27 mmol/l; p = 0.01). Multivariate analysis showed 
that hyperglycemia defined as glycemia >11mmol/L was an independent pre-
dictor factor for no-reflow (OR = 2.18, CI = 1.42 – 3.84; p = 0.002)
Conclusion: Hyperglycemia on admission is associated with higher risk of 
no-reflow in STEMI patients undergoing primary PCI.
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Relationship between balloon release pressure and ST resolution in 
STEMI patients undergoing primary PCI
Ouafa Hamza, Omar Ait Mokhtar, Abdelmalek Azzouz, Nabil Bendaoud, 
Mourad Saidane, Samia Latrèche, Khereddine Merad, Salim Benkhedda
CHU Mustapha, Cardiologie A2, Alger, Algérie
Background: The optimal balloon release pressure in primary percuta-
neous coronary intervention is not well established and use of high pressure 
may jeopardize ST resolution and increase the occurrence of no reflow.
Aim: To investigate the relationship between balloon release pressure and 
ST resolution in STEMI patients undergoing primary PCI.
Methods: Patients undergoing primary PCI for ST elevation myocardial 
infarction were enrolled and assigned into two groups according to the stent 
implantation pressure. High pressure group with a pressure >16 atm. Standard 
pressure <16 atm. The balloon pressure release was left to the operators’ dis-
cretion. No-reflow phenomenon was defined as Σ ST-segment resolution 
<70%
Results: 137 patients were enrolled with a mean age of 56.39 ± 12.8 years. 
The results showed that no-reflow phenomenon occurred more frequently in 
the high pressure group 49.32% vs 27%; p = 0.002. Furthermore, the high 
pressure group showed less ST resolution than the low pressure group with a 
mean ST-resolution 60.43 ± 25.86 vs 72.35 ± 18.13; p = 0.001
Conclusion: In primary PCI when stenting the culprit lesion, low pressure 
release may be better in avoiding the no reflow phenomenon
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Prevalence of glucose disoders in a cohort of patients hospitalized for 
ACS in coronary care unit, and security and efficiency of an intra-
veinous insulin protocol adapted on glycemic kinetic
Emilie Kamaryk (1), Arsène Monnier (2), Fabienne Amiot Chapoutot (3), 
Aurélie Marchais (1), Laurent Chapoutot (1), Pierre Nazeyrollas (2)
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Background: Glycemic variabilities have a negative impact on the mor-
bidity and mortality of acute coronary syndromes (ACS). A strict glucose 
monitoring is recommended on admission in Coronary Care Unit (CCU). The 
aims of our study were to assess the prevalence of various glucose disorders 
(diabete mellitus, impared fasting hyperglycemia, glucose intolerance, stress 
hyperglycemia) among patients hospitalized for ACS, and to assess the effi-
cency and security of an IV insulin protocol adapted on glycemic kinetic, to 
decrease the risk of hypoglycemia, and for which the goal was to stabilized 
glycemia between 1.10 and 1,40g/l.
Population and Method: This retrospective monocenter study concerns 
all patients admitted for ACS (STEMI and NSTEMI) in Troyes hospital from 
May 2012 to May 2013. The different glycemic parameters, capillarious and 
veinous were collect through analysis of medical reports.
Results: 164 patients were included. The mean age was 65 ± 13 years. 
Among them, 97 (59%) had diabete mellitus, and 8 (5%) had an intermediate 
disorder. Stress hyperglycemia was observed in 10 patients (11%) free from glu-
cose abnormalities. Among the patients without hystory of diabete mellitus and 
with hyperglycemia on admission, 53% were authentic diabetics. The IV insulin 
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protocol was initiated in 36 patients with a average baseline blood glucose 2.7 
± 0,7g/l. thirty-two were diabetics (31 type 2 and 1 and type 1) and diabete mel-
litus has been found on the occasion of the SCA in 4 of them with HbA1c 
>6.5%. The average time to reach a glycemia within the target range was 12.7 
± 11h. Only 3 patients (8%) had moderate hypoglycemia (<0.70g / l) and there 
were no severe hypoglycemia.
Conclusion: In this study, 59% of patients are diabetics, know or revealed 
at the opportunity of SCA, higher than the usual literature data. Hypergly-
cemia at admission reveals glucose disorder in 53% of cases. Our IV insulin 
protocol is safe and efficient.
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Radial vs femoral access after percutaneous coronary intervention for 
ST-segment elevation myocardial infarction. Thirty-day and one-year 
mortality results in Algerian cohort
Aziz Trichine, Hocine Foudad, Ilyes Bouaguel, Rachid Merghit
Hôpital Militaire, Cardiologie, Constantine, Algérie
Introduction and Objectives: Little attention has been given to the effect 
of vascular access site on mortality, while an increasing body of evidence is 
showing that radial access has much more benefit than femoral access for ST-
segment elevation myocardial infarction patients. We aimed to assess the 
influence of vascular access site on mortality at 30 days and at 1 year in ST-
segment elevation myocardial infarction patients.
Methods: We included all patients with ST-segment elevation myocardial 
infarction who had undergone angioplasty at military hospitals of Constantine 
and Algiers and the hospital of erriadh (ESH erriadh) between 2010 and 2013. 
We performed 2 multivariate regression models for each endpoint (30-day and 
1-year mortality). The only difference between these models was the inclusion 
or not of the vascular access site (femoral vs radial). We also tested the inter-
action between hemodynamic instability and vascular access.
Results: We included 395 patients with a mean age of 62. Of these 
patients, 32% had radial access and 7.4% had hemodynamic instability. All-
cause mortality was 8.6% (34/395) at 30 days and 13.1% (52/395) at 1 year. 
Vascular access site follows hemodynamic instability and age in terms of 
effect on mortality risk, with an odds ratio of 5.20 (95% confidence interval, 
2.80-9.66) for 30-day mortality. A similar effect occurs for 1-year mortality.
Conclusions: Vascular access site should be taken into account when pre-
dicting mortality after a primary percutaneous coronary intervention.
0064
Effect of acute heart failure following discharge in patients with non-
ST elevation acute coronary syndrome on the subsequent risk of death 
or acute myocardial infarction: Algerian experience
Aziz Trichine, Hocine Foudad, Ilyes Bouaguel, Rachid Merghit
Hôpital Militaire, Cardiologie, Constantine, Algérie
Introduction and Objectives: Little is known about how prognosis is 
influenced by readmission for acute heart failure (AHF) following non-ST-
segment elevation acute coronary syndrome (NSTEACS). The aim of this 
study was to determine the prognostic effect of a first admission for AHF on 
the risk of acute myocardial infarction (AMI) or death in patients who sur-
vived an episode of high-risk NSTEACS.
Methods: The study involved 342 consecutive patients with high-risk 
NSTEACS who survived after hospital admission in military hospital of 
Algiers and Constantine. Readmission for AHF was selected as the main 
exposure variable, and its association with subsequent AMI or all-cause death 
was assessed using Cox proportional hazards models for time-dependent 
covariates that also included adjustment for competing risks. Results: After a 
median follow-up period of 30 [interquartile range, 12-48] months, 29 patients 
(8.4%) were admitted for AHF, 51(15%) had an AMI, and 71 (20.8%) died. 
The median time to readmission for AHF was 193 [56-336] days after 
NSTEACS. Patients readmitted for AHF had an increased risk of subsequent 
death (hazard ratio [HR]=1.67; 95% confidence interval [CI], 1.13-2.45; 
P=.009) or AMI (HR=2.15; 95% CI, 1.41-3.27; P<.001), which was indepen-
dent of baseline prognostic and time-dependent variables.
Conclusions: Readmission for AHF after high-risk NSTEACS was associ-
ated with an increased risk of subsequent death or AMI.
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Optimal therapeutic management improves long-term survival in ST-
elevation myocardial infarction patients with altered glomerular 
filtration rate. A propensity score comparison
Nathan Mewton, Fabien Subtil, Julie Mahé, Danka Tomasevic, Oualid 
Zouaghi, Brigitte De Breyne, Michel Ovize, Eric Bonnefoy-Cudraz
Hôpital Cardiovasculaire Louis Pradel, Centre d’Investigation Clinique, 
Bron, France
Introduction: Decreased glomerular filtration rate (GFR) is associated 
with an increased risk of cardiovascular events following acute ST elevation 
myocardial infarction (STEMI). However, patients with chronic kidney dis-
ease have more comorbidities and will receive fewer evidence-based therapies
In a prospective STEMI patient cohort we assessed the effect of an optimal 
therapeutic management (OTM) according to GFR categories on long-term 
all-cause mortality.
Methods: In a single tertiary referral center, 1,199 patients admitted for 
acute STEMI were enrolled between 2007 and 2011. We classified patients 
into 4 categories according to estimated GFR, <45, 45 to 60, 60 to 90, and 
>90mL/min/1,73m2 with the Chronic Kidney Disease Epidemiology Collabo-
ration (CKD EPI) equation. Optimal therapeutic management was defined as 
a combination of reperfusion within 12 hours of symptom onset, primary 
percutaneous coronary intervention (PCI), double anti-platelet regimen, 
angiotensin converting enzyme inhibitors, statins, beta blockers, and anti-
aldosterone treatment (if left ventricle ejection fraction <40%) upon discharge. 
The effect of OTM on survival according to GFR categories was analysed in 
a multivariate survival model including other risk factors and using a propen-
sity score method. Long-term mortality was the principal endpoint.
Results: Patients were followed-up for a median of 4.7 years and 
148(12.3%) patients died. OTM was applied in 431 (39.1%) patients of our 
cohort and overall, was associated with a significantly lower mortality (HR of 
0.43 [95% CI, 0.26-0.70; P<0.001). There was a significant mortality reduc-
tion in the OTM group compared to the non-OTM group that tended to 
increase with increasing levels of renal dysfunction (HR of 0.28 [95% CI, 
0.13-0.61] in the eGFR<60ml/min patient subgroup; P=0.001) (Figure 1). 
Conclusions: OTM lowers long-term mortality whatever the eGFR cate-
gory and with a trend towards increased efficiency with increasing levels of 
renal dysfunction.
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